Headache Relief
- Product NDC
- 49035-433
- Requested package NDC
- 49035-433-85
- 11-digit product format
- 490350433
- Labeler code
- 49035
- Product ID
- 49035-433_a5077198-1083-408b-9727-b89909de0558
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Aspirin and Caffeine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Wal-Mart Stores Inc
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2008-03-13
- Substance
- ACETAMINOPHEN; ASPIRIN; CAFFEINE
- Active strength
- 250; 250; 65 mg/1; mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 49035-433 | 49035-433-85 | D | Discontinued by firm | 2026-10-23 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Headache Relief
- Brand name suffix
- Extra Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 250 mg/1 |
| ASPIRIN | 250 mg/1 |
| CAFFEINE | 65 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| R16CO5Y76E | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 308297 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9b1201af-c802-4e19-b192-bbbf34367db4 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49035-433-06 | Headache ReliefExtra Strength | 2 in 1 CARTON | TABLET, FILM COATED | 2 | 17 | |
| 49035-433-08 | Headache ReliefExtra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 17 | |
| 49035-433-08 | Headache ReliefExtra Strength | 24 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 24 | 17 | |
| 49035-433-12 | Headache ReliefExtra Strength | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 17 | |
| 49035-433-85 | Headache ReliefExtra Strength | 200 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 200 | 17 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49035-433-06 | EA - Each | 49035-433 | 733cc245-97e9-47ca-84a4-cd7448ce0734 | 1 | 2024-04-05 |
| 49035-433-08 | EA - Each | 49035-433 | 110860f9-5ace-49e2-b01c-da9c7062a828 | 1 | 2019-08-06 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49035-433 | HEADACHE RELIEF EXTRA STRENGTH (ACETAMINOPHEN, ASPIRIN AND CAFFEINE) TABLET, FILM COATED [WAL-MART STORES INC] | 16 | Current NDC, Legacy NDC, 5 package rows | 20250501_9b1201af-c802-4e19-b192-bbbf34367db4.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen | ACETAMINOPHEN | Aurohealth LLC | 30756257-f748-4a5d-b031-dd267d0f91ad | 2023-11-29 | Warnings | M013 |
| Aurophen Regular Strength | ACETAMINOPHEN | Aurohealth LLC | 8eda893f-5266-4b7a-95b9-2e194973cf06 | 2023-11-29 | Warnings | M013 |
| Childrens Pain Relief | ACETAMINOPHEN | Aurohealth LLC | 00ec6518-b5e3-49d1-a342-139381c3bfd2 | 2023-11-29 | Warnings | M013 |
| CHILDRENS PAIN RELIEF | ACETAMINOPHEN | Better Living Brands, LLC | fadb4c09-071f-56c0-e053-6294a90ae6c1 | 2023-11-28 | Warnings | M013 |
| Acetaminophen and Diphenhydramine hydrochloride | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Better Living Brands, LLC | fc07d516-9ffe-9989-e053-6294a90ae1a5 | 2023-11-28 | Warnings | M013 |
| NOTTS - Tension Headache | ACETAMINOPHEN, CAFFEINE | VIVUNT PHARMA LLC | 08f2ae03-967b-ad7e-e063-6294a90a8484 | 2023-11-24 | Warnings | M013 |
| Sanatos Multi Symptoms Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | Pharmadel LLC | 0a60326a-a17b-e843-e063-6394a90ac211 | 2023-11-22 | Warnings | M013 |
| Sanatos Nighttime Multi Symptoms | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | Pharmadel LLC | 0ab188f3-f7f9-d665-e063-6294a90a198a | 2023-11-22 | Warnings | M013 |
| ASPIRIN | ASPIRIN | TIME CAP LABS INC | fe12519c-3e5f-4592-bd34-2d6b81b981f4 | 2023-11-22 | Warnings | M013 |
| Rugby Regular Strength Acetaminophen | ACETAMINOPHEN | A-S Medication Solutions | 400d4a29-9e39-4e74-8272-37be5d789924 | 2023-11-22 | Warnings | M013 |
| RIGHT REMEDIES Pain Relief Extra Strength Caplet | ACETAMINOPHEN | Strive Pharmaceuticals Inc. | dcce28d9-8528-489e-b995-1d98e9d0e6ad | 2023-11-21 | Warnings | M013 |
| Sanatos Multi Symptom Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCI | Pharmadel LLC | 0ab11691-5b29-55fc-e063-6394a90aa328 | 2023-11-17 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | A-S Medication Solutions | 1e223faa-f6d0-4235-bc4c-6cfca84a5b0a | 2023-11-17 | Warnings | M013 |
| SanaTos X | ACETAMINOPHEN, DEXTROMETHORPHAN HBR,GUAIFENESIN, PHENYLEPHRINE HCI | Pharmadel LLC | 85b8ef3d-7318-7f3b-e053-2991aa0a0777 | 2023-11-14 | Warnings | M013 |
| RIGHT REMEDIES EXTRA STRENGTH PM Pain Relief | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | Strive Pharmaceuticals Inc. | 8badbaad-eb35-4251-a779-00474819360d | 2023-11-13 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Trifecta Pharmaceuticals USA LLC | 09935a74-34b0-0e7c-e063-6294a90a7c83 | 2023-11-07 | Warnings | M013 |
| Pain Relief PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | AMERIFOODS TRADING COMPANY | f6dd6396-93e9-1096-e053-6394a90af06d | 2023-11-02 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | RETAIL BUSINESS SERVICES , LLC. | eb644e9e-36dc-5f84-e053-2a95a90affa5 | 2023-11-02 | Warnings | M013 |
| Good Sense Childrens Pain and Fever | ACETAMINOPHEN | Proficient Rx LP | 46527b1f-7515-44ce-b5cb-9d24223b9af1 | 2023-11-01 | Warnings | M013 |
| Aspirin | ASPIRIN | A-S Medication Solutions | 12feb32b-4b8c-4b17-9e86-cb286457b088 | 2023-11-01 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | PSN | 9b1201af-c802-4e19-b192-bbbf34367db4 | 17 |
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | SCD | 9b1201af-c802-4e19-b192-bbbf34367db4 | 17 |
| 308297 | APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet | SY | 9b1201af-c802-4e19-b192-bbbf34367db4 | 17 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 49035-433-85 | 49035043385 | 200 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (49035-433-85) | 2008-03-13 | 0000-00-00 | No | No | Current |